The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer

Patients with inflammatory bowel disease (IBD) have an increased risk of cancer secondary to chronic inflammation and long-term use of immunosuppressive therapy. With the aging IBD population, the prevalence of cancer in IBD patients is increasing. As a result, there is increasing concern about the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetwittayakhlang, Panu, Tselekouni, Paraskevi, Al-Jabri, Reem, Bessissow, Talat, Lakatos, Peter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056442/
https://www.ncbi.nlm.nih.gov/pubmed/36983432
http://dx.doi.org/10.3390/jcm12062432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056442/
https://www.ncbi.nlm.nih.gov/pubmed/36983432
http://dx.doi.org/10.3390/jcm12062432

Ejemplares similares